EMGLIF-LM XR 10/5/1000MG 28S TAB

Emglif-LM XR 10/5/1000mg Tablet is an extended-release triple combination antidiabetic medication containing Empagliflozin, Linagliptin, and Metformin. It is specially formulated to help control blood sugar levels in adults with Type 2 Diabetes Mellitus. This advanced formulation works through three complementary mechanisms—reducing glucose absorption, enhancing insulin sensitivity, and promoting glucose excretion through urine—for comprehensive glycemic control and improved metabolic health.

Uses:

• Helps manage Type 2 Diabetes Mellitus effectively

• Controls blood glucose levels and improves insulin sensitivity

• Reduces risk of heart and kidney complications in diabetic patients

• Supports weight management and reduces excess body fat

• Used as part of a diet and exercise regimen for long-term diabetic control

Benefits:

• Triple-action formula (Empagliflozin + Linagliptin + Metformin) for superior glucose control

• Extended-release technology for sustained blood sugar regulation throughout the day

• Helps reduce HbA1c and improve insulin response

• Once-daily dosing for better adherence and convenience

• May aid in weight loss and cardiovascular protection

Possible Side Effects:

• Frequent urination, increased thirst, or mild dehydration

• Gastrointestinal symptoms like nausea or diarrhea (common with Metformin)

• Genital or urinary infections due to increased glucose excretion

• Rarely, low blood pressure or hypoglycemia (especially with other antidiabetics)

• Seek medical advice if you experience persistent fatigue, dizziness, or unusual symptoms